These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38653249)

  • 1. Gene-specific somatic epigenetic mosaicism of FDFT1 underlies a non-hereditary localized form of porokeratosis.
    Saito S; Saito Y; Sato S; Aoki S; Fujita H; Ito Y; Ono N; Funakoshi T; Kawai T; Suzuki H; Sasaki T; Tanaka T; Inoie M; Hata K; Kataoka K; Kosaki K; Amagai M; Nakabayashi K; Kubo A
    Am J Hum Genet; 2024 May; 111(5):896-912. PubMed ID: 38653249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal Expansion of Second-Hit Cells with Somatic Recombinations or C>T Transitions Form Porokeratosis in MVD or MVK Mutant Heterozygotes.
    Kubo A; Sasaki T; Suzuki H; Shiohama A; Aoki S; Sato S; Fujita H; Ono N; Umegaki-Arao N; Kawai T; Nakabayashi K; Hata K; Yamada D; Matsubara Y; Kosaki K; Amagai M
    J Invest Dermatol; 2019 Dec; 139(12):2458-2466.e9. PubMed ID: 31207227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-Hit, Postzygotic PMVK and MVD Mutations in Linear Porokeratosis.
    Atzmony L; Khan HM; Lim YH; Paller AS; Levinsohn JL; Holland KE; Mirza FN; Yin E; Ko CJ; Leventhal JS; Choate KA
    JAMA Dermatol; 2019 May; 155(5):548-555. PubMed ID: 30942823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in mevalonate pathway genes in patients with familial or sporadic porokeratosis.
    Leng Y; Yan L; Feng H; Chen C; Wang S; Luo Y; Cao L
    J Dermatol; 2018 Jul; 45(7):862-866. PubMed ID: 29722423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porokeratosis Plantaris, Palmaris et Disseminata Caused by Con- genital Pathogenic Variants in the MVD Gene and Loss of Hetero-zygosity in Affected Skin.
    Jägle S; Juratli HA; Hickman G; Süssmuth K; Boente MC; Kopp J; Kirchmeier P; Zimmer A; Happle R; Bourrat E; Hamm H; Fischer J
    Acta Derm Venereol; 2021 Feb; 101(2):adv00397. PubMed ID: 33491095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss-of-function Mutation in PMVK Causes Autosomal Dominant Disseminated Superficial Porokeratosis.
    Wang J; Liu Y; Liu F; Huang C; Han S; Lv Y; Liu CJ; Zhang S; Qin Y; Ling L; Gao M; Yu S; Li C; Huang M; Liao S; Hu X; Lu Z; Liu X; Jiang T; Tang Z; Zhang H; Guo AY; Liu M
    Sci Rep; 2016 Apr; 6():24226. PubMed ID: 27052676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic variations of the mevalonate pathway in porokeratosis.
    Zhang Z; Li C; Wu F; Ma R; Luan J; Yang F; Liu W; Wang L; Zhang S; Liu Y; Gu J; Hua W; Fan M; Peng H; Meng X; Song N; Bi X; Gu C; Zhang Z; Huang Q; Chen L; Xiang L; Xu J; Zheng Z; Jiang Z
    Elife; 2015 Jul; 4():e06322. PubMed ID: 26202976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.
    Atzmony L; Lim YH; Hamilton C; Leventhal JS; Wagner A; Paller AS; Choate KA
    J Am Acad Dermatol; 2020 Jan; 82(1):123-131. PubMed ID: 31449901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the ultraviolet B and X-ray response of primary cultured epidermal cells from patients with disseminated superficial actinic porokeratosis.
    D'Errico M; Teson M; Calcagnile A; Corona R; Didona B; Meschini R; Zambruno G; Dogliotti E
    Br J Dermatol; 2004 Jan; 150(1):47-55. PubMed ID: 14746616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations in mevalonate kinase cause disseminated superficial actinic porokeratosis.
    Zhu T; Tian D; Zhang L; Xu X; Xia K; Hu Z; Xiong Z; Tan J
    Br J Dermatol; 2019 Aug; 181(2):304-313. PubMed ID: 30597534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel missense mutations of MVK and FDPS gene in Chinese patients with disseminated superficial actinic porokeratosis.
    Li L; Zuo N; Yang D; Zhang D; Feng Y; Li X
    Clin Chim Acta; 2021 Dec; 523():441-445. PubMed ID: 34751146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating linear porokeratosis with topical lovastatin/cholesterol cream.
    Buhle AC; Fagan KK; Johnson NM; Grider DJ
    Dermatol Online J; 2022 Oct; 28(5):. PubMed ID: 36809136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-Hit Somatic Mutations in Mevalonate Pathway Genes Underlie Porokeratosis.
    Atzmony L; Choate KA
    J Invest Dermatol; 2019 Dec; 139(12):2409-2411. PubMed ID: 31753123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis.
    Zhang SQ; Jiang T; Li M; Zhang X; Ren YQ; Wei SC; Sun LD; Cheng H; Li Y; Yin XY; Hu ZM; Wang ZY; Liu Y; Guo BR; Tang HY; Tang XF; Ding YT; Wang JB; Li P; Wu BY; Wang W; Yuan XF; Hou JS; Ha WW; Wang WJ; Zhai YJ; Wang J; Qian FF; Zhou FS; Chen G; Zuo XB; Zheng XD; Sheng YJ; Gao JP; Liang B; Li P; Zhu J; Xiao FL; Wang PG; Cui Y; Li H; Liu SX; Gao M; Fan X; Shen SK; Zeng M; Sun GQ; Xu Y; Hu JC; He TT; Li YR; Yang HM; Wang J; Yu ZY; Zhang HF; Hu X; Yang K; Wang J; Zhao SX; Zhou YW; Liu JJ; Du WD; Zhang L; Xia K; Yang S; Wang J; Zhang XJ
    Nat Genet; 2012 Oct; 44(10):1156-60. PubMed ID: 22983302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
    Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
    Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of porokeratosis.
    Zhang ZH; Wang ZM; Crosby ME; Wang HF; Xiang LH; Luan J; Gu CY; Zhou J; Niu ZM; Fang X; Huang W; Zheng ZZ
    J Cutan Pathol; 2008 Nov; 35(11):1058-62. PubMed ID: 18727663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel PMVK Variant Associated with Familial Porokeratosis.
    Zhang W; Nie X; Shi L; Shao F; Cao L
    Hum Hered; 2023; 88(1):50-57. PubMed ID: 37315547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature apoptosis of keratinocytes and the dysregulation of keratinization in porokeratosis.
    Shen CS; Tabata K; Matsuki M; Goto T; Yokochi T; Yamanishi K
    Br J Dermatol; 2002 Sep; 147(3):498-502. PubMed ID: 12207590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 alterations in porokeratosis.
    Arranz-Salas I; Sanz-Trelles A; Ojeda DB
    J Cutan Pathol; 2003 Aug; 30(7):455-8. PubMed ID: 12859744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Dominantly Inherited 5' UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer.
    Evans DGR; van Veen EM; Byers HJ; Wallace AJ; Ellingford JM; Beaman G; Santoyo-Lopez J; Aitman TJ; Eccles DM; Lalloo FI; Smith MJ; Newman WG
    Am J Hum Genet; 2018 Aug; 103(2):213-220. PubMed ID: 30075112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.